Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

11.76
Delayed Data
As of 3:59pm ET
 -0.16 / -1.34%
Today’s Change
8.18
Today|||52-Week Range
15.20
+19.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues31.9M39.0M29.6M33.8M
 
 
 
 
 
Cost of Goods Sold8.5M7.4M6.9M7.2M
 
 
 
 
 
Depreciation And Amortization654.0K644.0K602.0K600.0K
 
 
 
 
 
 
Operating ExpensesGross Income22.7M31.0M22.0M26.0M
 
 
 
 
 
General Expenses45.5M53.6M49.6M51.4M
 
 
 
 
 
Research And Development33.9M41.3M36.9M38.3M
 
 
 
 
 
Total Operating Expenses54.6M61.6M57.1M59.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.7M-22.6M-27.5M-25.5M
 
 
 
 
 
Interest Expense On Debt5.3M5.6M5.4M5.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.7M-27.8M-32.7M-30.6M
 
 
 
 
 
Income Taxes-1.3M-422.0K-210.0K-180.0K
 
 
 
 
 
Net Income-28.9M-27.4M-32.9M-30.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS128.2M128.2M128.6M134.0M
 
 
 
 
 
Shares To Calculate EPS Diluted128.2M128.2M128.6M134.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.23-$0.21-$0.26-$0.23
 
 
 
 
 
EPS Diluted-$0.23-$0.21-$0.26-$0.23